Abstract
Objective Uptake for cervical cancer screening remains well below the recommended rate of 80%. We conducted a preliminary study to determine the reasons for non-attendance and explore their acceptance of human papillomavirus (HPV) self-sampling as an alternative to the Pap test.
Methods A cross-sectional study was conducted at a health center in Brunei, from January to December 2019. Women who were eligible for Pap test but who either never or did not have one within the past four years were conveniently recruited. Participants were first asked to complete a paper-based survey on their reasons for screening non-attendance, and then invited for HPV self-sampling. Results were analyzed using descriptive and inferential statistics.
Result We enrolled 174 screening non-attendees, out of which 97 (55.7%) also participated in HPV self-sampling. The main reasons for not attending Pap test screening were fear of bad results (16.1%, n = 28); embarrassment (14.9%, n = 26) and lack of time due to home commitments (10.3%, n = 18). When compared to those who agreed to participate in HPV self-sampling, those who declined were significantly older (p = 0.002) and less likely to agree that they are susceptible to cervical cancer (p = 0.023). They preferred to receive Pap test-related information from healthcare workers (59.0%, n = 155), social messaging platforms (28.7%, n = 51) and social media (26.4%, n = 47). HPV self-sampling kits were positively received, where > 90% agreed on its ease and convenience. Nine of 97 participants (9.3%) tested positive for hr-HPV, out of which eight were non-16/18 HPV genotypes.
Conclusion Our findings suggest that promoting knowledge on cervical cancer, the benefits of screening and clarifying any misconceptions of Pap test results would help increase screening uptake among Bruneian non-attendees. Response to HPV self-sampling was highly positive, implying its receptiveness in the local setting. Our high detection of non-16/18 HPV genotypes suggest high prevalence of other hr-HPV genotypes in Brunei. Larger studies can be conducted to further validate our findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this study was obtained from the Ministry of Health, Brunei Darussalam.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was obtained from the Medical and Health Research and Ethics Committee (MHREC), Ministry of Health, Brunei Darussalam [Reference no. MHREC/MOH/2018/9(2)].
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos